glp-1 drug least chemical modification PDB-101: Diabetes Mellitus: Diabetes Mellitus: undefined: Semaglutide Science Behind GLP 1 GIP
Description
We know that patients taking GLP-1 RAs have an increased incidence of residual gastric contents even when fasting
This condition, telogen effluvium , is temporary and reversible
doi: 10.1016/j.jchf.2024.07.006 [DOI] [PubMed] [Google Scholar] 6.Khadke S, Kumar A, Bhatti A, et al
Upon matching, these differences were highly attenuated, and matching was satisfactory
When it comes to side effects, the safety profile tells us that some people get common side effects, but these are often mild and can be managed
